Skystar Bio Pharmaceutical Company reported consolidated unaudited earnings results for the second quarter ended July 30, 2012. For the quarter, the company reported revenue, net was $8,870,848 against $9,096,141 a year ago. Income from operations was $2,288,531 against $1,532,464 a year ago. Income before provision for income taxes was $2,281,640 against $1,789,095 a year ago. Net income was $1,698,866 against $1,507,390 a year ago. Diluted earnings per share was $0.23 against $0.21 per share a year ago.

For the six months, the company reported revenue, net was $16,797,185 against $16,183,095 a year ago. Income from operations was $4,756,505 against $3,176,398 a year ago. Income before provision for income taxes was $4,655,362 against $4,198,377 a year ago. Net income was $3,603,620 against $3,439,222 a year ago. Diluted earnings per share was $0.48 against $0.48 per share a year ago. Net cash used in operating activities was $2,163,439 against $3,922,845 a year ago. Purchases of property, plant and equipment was $127,531 against $46,186 a year ago.

The company currently reiterate fiscal 2012 guidance to be in the range of $53 million to $57 million for the full year.